Heidelberg, Germany

Klaus-Juergen Hahn

This inventor holds 1 USPTO granted patent. Top assignee: Basf Aktiengesellschaft. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus-Juergen Hahn. Retrieved from https://idiyas.com/inventor/klaus-juergen-hahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Klaus-Juergen Hahn

Introduction

Klaus-Juergen Hahn is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of circulatory disorders. His innovative approach has led to the development of a unique combination preparation that showcases his expertise.

Latest Patents

Klaus-Juergen Hahn holds a patent for a combination preparation that includes verapamil, gallopamil, or anipamil along with acetylsalicylic acid. This combination is formulated in a weight ratio ranging from 10:1 to 2:1, making it useful in the treatment of circulatory disorders. This patent highlights his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Hahn is associated with BASF Aktiengesellschaft, a leading company in the chemical industry. His work at BASF has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development in pharmaceuticals.

Collaborations

Throughout his career, Klaus-Juergen Hahn has worked alongside esteemed colleagues such as Rolf Kretzschmar and Hans D Lehmann. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Klaus-Juergen Hahn's contributions to the field of medicine through his innovative patent demonstrate his dedication to improving healthcare. His work continues to inspire future advancements in the treatment of circulatory disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…